IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
128 hedge funds and large institutions have $536M invested in IVERIC bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 12 closing their positions.
207% more call options, than puts
Call options by funds: $2.26M | Put options by funds: $737K
108% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 12
11% more funds holding
Funds holding: 115 → 128 (+13)
8% more capital invested
Capital invested by funds: $495M → $536M (+$40.8M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 39
Top Buyers
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$5.32M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.69M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.23M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.16M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.79M |
ISEE Hedge Fund Activity: Q2 2021 in Review
128 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2021, worth a combined $536M — up 8.2% from $495M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ISEE positions and 12 closed out — a net gain of 13 holders — while 39 added to existing stakes and 39 trimmed.
The largest buyer was Yiheng Capital Management, adding an estimated $14.7M. The largest seller was Avoro Capital Advisors, cutting an estimated $5.32M.
- 128 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2021, up from 115 in Q1 2021.
- Funds reported $536M of IVERIC bio, Inc. Common Stock stock for Q2 2021, up 8.2% quarter-over-quarter.
- 25 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2021 and 12 closed out, a net change of +13 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q2 2021 was Yiheng Capital Management, an estimated $14.7M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q2 2021 was Avoro Capital Advisors, an estimated $5.32M sold.
Based on aggregated 13F filings for Q2 2021.